Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce the Risk of Hospitalization and CV Mortality? Why Cardiologist Must Intervene in T2D?

103 views
January 15, 2021
Comments 1
Login to view comments. Click here to Login